Adam Daniel Cutler

Adam Daniel Cutler

Plus aucun poste en cours

Fortune : 385 621 $ au 31/03/2024

50 ans
Finance
Health Technology
Commercial Services

Profil

Mr. Adam D.
Cutler is a Chief Financial & Accounting Officer at Mural Oncology Plc.
Mr. Cutler was previously employed as a Chief Financial Officer by Q32 Bio, Inc. (Massachusetts), an Independent Director by Navidea Biopharmaceuticals, Inc., a Chief Financial Officer, Secretary & Treasurer by Molecular Templates, Inc., an Independent Director by InMed Pharmaceuticals, Inc., a Senior Vice President-Corporate Affairs by Arbutus Biopharma Corp., a Managing Director by The Trout Group LLC, a Managing Director by Trout Capital LLC, a Managing Director by Canaccord Genuity, Inc., an Associate Analyst by Banc of America Securities LLC, a Research Analyst by Credit Suisse Securities (USA) LLC (Broker), an Analyst by The Frankel Group Associates LLC, and a Consultant by Ernst & Young LLP.
He also served on the board at JMP Securities LLC.
He received his undergraduate degree from Brandeis University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
0,47%
14/12/2023 78 859 ( 0,47% ) 385 621 $ 31/03/2024

Postes actifs de Adam Daniel Cutler

Anciens postes connus de Adam Daniel Cutler

SociétésPosteFin
Director of Finance/CFO 01/10/2023
INMED PHARMACEUTICALS INC. Director/Board Member 08/08/2022
MOLECULAR TEMPLATES, INC. Director of Finance/CFO 02/07/2021
NAVIDEA BIOPHARMACEUTICALS, INC. Director/Board Member 04/05/2021
ARBUTUS BIOPHARMA CORPORATION Corporate Officer/Principal 01/11/2017
Voir l'expérience en détail de Adam Daniel Cutler

Formation de Adam Daniel Cutler

Brandeis University Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Adam Daniel Cutler

Relations

100 +

Relations au 1er degré

13

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées4
NAVIDEA BIOPHARMACEUTICALS, INC.

Health Technology

ARBUTUS BIOPHARMA CORPORATION

Health Technology

INMED PHARMACEUTICALS INC.

Health Technology

MOLECULAR TEMPLATES, INC.

Health Technology

Entreprise privées8

Finance

Finance

Commercial Services

Finance

Finance

Finance

Finance

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Adam Daniel Cutler